STAN angel investors say they have invested in HarborSite
STAN says it is backing the US company led by Armenian co-founder Eric Aznauryan as the team works to turn gene-engineering research into lasting treatments.
Loading… Բեռնվում է…
STAN says it is backing the US company led by Armenian co-founder Eric Aznauryan as the team works to turn gene-engineering research into lasting treatments.
STAN’s angel investors say they have invested in HarborSite, a US biotechnology company co-founded and led by Armenian Eric Aznauryan. The company has joined STAN’s investment portfolio, How2B said. The investment amount, ownership stake and terms are undisclosed.
HarborSite emerged from George Church’s laboratory. Earlier work at the Wyss Institute at Harvard University focused on refining the technology: in its March 18, 2024 account, the institute said the team was working toward forming a startup and eventually reaching clinical use.
HarborSite describes an approach that inserts disease-modifying genes into genetic material to develop treatments for inherited and age-related diseases. Its goal is a treatment whose effects last for life after a single administration.
The Wyss Institute’s March 18, 2024 account described a design using recombinases—enzymes that insert DNA—to place large DNA sequences at selected locations in the genome, a cell’s genetic material. The aim was to make therapeutic genes work predictably, safely and for the long term. At that time, the team was focusing on diseases potentially treatable by inserting genes into liver cells, including hemophilia.
Wyss described Erik Aznauryan’s research role as finding suitable insertion locations and evaluating how safely and efficiently insertions worked in different cell types.
Wyss selected HarborSite as a 2022–2023 Validation Project and renewed it for 2023–2024. That program provided dedicated funding, business-development support and other resources to refine the technology.
The bank left rates unchanged on October 29, 2026, and said it would decide its next moves meeting by meeting as energy prices continued to rise.
1 min
STAN describes itself as a network connecting experienced angel investors with early-stage technology startups. It says its investors offer funding, mentorship and international connections.
HarborSite’s current clinical stage, any results in patients and a timetable for clinical trials remain undisclosed. STAN’s representatives say they are supporting the team’s effort to turn years of research at the Wyss Institute at Harvard University into long-term treatments.
Walmart plans additional automation at 25 US regional distribution centres under the multiyear agreement, which also supports its global supply chain.
2 min
The satellite operator expects access to more than twice OneWeb’s current bandwidth in return for spending in 2027–2034, with initial IRIS² services expected from 2030.
3 min